1 - 25 of 97 results for author:"Bergeron J." in Literature citations
Results Customize
› Repeat search in UniProtKB (105)
| Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARgamma deficiency. Campeau P.M., Astapova O., Martins R., Bergeron J., Couture P., Hegele R.A., Leff T., Gagne C. J. Lipid Res. 53:1968-1978(2012) · Mapped (9) |
| TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRalpha gene expression. Dadi S., Le Noir S., Payet-Bornet D., Lhermitte L., Zacarias-Cabeza J., Bergeron J., Villarese P., Vachez E., Dik W.A., Millien C. et al. Cancer Cell 21:563-576(2012) · Mapped (18) |
| Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men. Pelletier-Beaumont E., Arsenault B.J., Almeras N., Bergeron J., Tremblay A., Poirier P., Despres J.P. Atherosclerosis 221:577-582(2012) · Mapped (12) |
| Genetic contribution to C-reactive protein levels in severe obesity. Faucher G., Guenard F., Bouchard L., Garneau V., Turcot V., Houde A., Tchernof A., Bergeron J., Deshaies Y., Hould F.S. et al. Mol. Genet. Metab. 105:494-501(2012) · Mapped (3) |
| Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication. Sherer N.M., Swanson C.M., Hue S., Roberts R.G., Bergeron J.R., Malim M.H. PLoS Pathog. 7:e1002395-e1002395(2011) · Mapped (6) |
| Crystal structure of TtgV in complex with its DNA operator reveals a general model for cooperative DNA binding of tetrameric gene regulators. Lu D., Fillet S., Meng C., Alguel Y., Kloppsteck P., Bergeron J., Krell T., Gallegos M.T., Ramos J., Zhang X. Genes Dev. 24:2556-2565(2010) · Mapped (1) |
| Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology. Larocque D., Sanderson N.S., Bergeron J., Curtin J.F., Girton J., Wibowo M., Bondale N., Kroeger K.M., Yang J., Lacayo L.M. et al. Proc. Natl. Acad. Sci. U.S.A. 107:14443-14448(2010) · Mapped (3) |
| Structural insights into serine-rich fimbriae from gram-positive bacteria. Ramboarina S., Garnett J.A., Zhou M., Li Y., Peng Z., Taylor J.D., Lee W.C., Bodey A., Murray J.W., Alguel Y. et al. J. Biol. Chem. 285:32446-32457(2010) · UniProtKB (1) |
| AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Short J.D., Dere R., Houston K.D., Cai S.L., Kim J., Bergeron J.M., Shen J., Liang J., Bedford M.T., Mills G.B. et al. Mol. Carcinog. 49:429-439(2010) · Mapped (4) |
| Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity. Bouchard L., Vohl M.C., Lebel S., Hould F.S., Marceau P., Bergeron J., Perusse L., Mauriege P. Obes Surg 20:492-499(2010) · Mapped (4) |
| Sorting out glycosylation enzymes in the Golgi apparatus. Nilsson T., Au C.E., Bergeron J.J. FEBS Lett. 583:3764-3769(2009) · Mapped (1) |
| Calnexin phosphorylation attenuates the release of partially misfolded alpha1-antitrypsin to the secretory pathway. Cameron P.H., Chevet E., Pluquet O., Thomas D.Y., Bergeron J.J. J. Biol. Chem. 284:34570-34579(2009) · Mapped (11) |
| Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity. Cartier A., Cote M., Bergeron J., Almeras N., Tremblay A., Lemieux I., Despres J.P. Clin. Endocrinol. (Oxf) 72:349-357(2010) · Mapped (13) |
| The evolution of 5S ribosomal RNA genes linked to the rDNA units of fungal species. Bergeron J., Drouin G. Curr. Genet. 54:123-131(2008) · Mapped (4) |
| Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., Friedman E., Narod S., Olshen A.B., Gregersen P. et al. Proc. Natl. Acad. Sci. U.S.A. 105:4340-4345(2008) · UniProtKB (1) · Mapped (4) |
| T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome. Baleydier F., Decouvelaere A.V., Bergeron J., Gaulard P., Canioni D., Bertrand Y., Lepretre S., Petit B., Dombret H., Beldjord K. et al. Clin. Cancer Res. 14:692-700(2008) · Mapped (1) |
| Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes. Perron P., Brisson D., Santure M., Blackburn P., Bergeron J., Vohl M.C., Despres J.P., Gaudet D. J. Endocrinol. Invest. 30:551-557(2007) · Mapped (15) |
| Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs. Bergeron J., Clappier E., Radford I., Buzyn A., Millien C., Soler G., Ballerini P., Thomas X., Soulier J., Dombret H. et al. Blood 110:2324-2330(2007) · Mapped (1) |
| Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Hageman G.S., Hancox L.S., Taiber A.J., Gehrs K.M., Anderson D.H., Johnson L.V., Radeke M.J., Kavanagh D., Richards A., Atkinson J. et al. Ann. Med. 38:592-604(2006) · Mapped (22) |
| Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes. Hogue J.C., Lamarche B., Tremblay A.J., Bergeron J., Gagne C., Couture P. J. Lipid Res. 48:1336-1342(2007) · Mapped (12) |
| AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesis. Carpenter E.P., Corbett A., Thomson H., Adacha J., Jensen K., Bergeron J., Kasampalidis I., Exley R., Winterbotham M., Tang C. et al. EMBO J. 26:1363-1372(2007) · UniProtKB (2) |
| Population distribution of the functional caspase-12 allele. Kachapati K., O'Brien T.R., Bergeron J., Zhang M., Dean M. Hum. Mutat. 27:975-975(2006) · UniProtKB (1) |
| Visceral adiposity and endothelial lipase. Paradis M.E., Badellino K.O., Rader D.J., Tchernof A., Richard C., Luu-The V., Deshaies Y., Bergeron J., Archer W.R., Couture P. et al. J. Clin. Endocrinol. Metab. 91:3538-3543(2006) · Mapped (1) |
| Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. Cai S.L., Tee A.R., Short J.D., Bergeron J.M., Kim J., Shen J., Guo R., Johnson C.L., Kiguchi K., Walker C.L. J. Cell Biol. 173:279-289(2006) |
| Gene polymorphisms in the Quebec population: a risk to develop hypertriglyceridemia. Garenc C., Aubert S., Laroche J., Bergeron J., Gagne C., Rousseau F., Julien P. Biochem. Biophys. Res. Commun. 344:588-596(2006) · Mapped (23) |